[HTML][HTML] Skeletal muscle quantitative nuclear magnetic resonance imaging and spectroscopy as an outcome measure for clinical trials

PG Carlier, B Marty, O Scheidegger… - Journal of …, 2016 - content.iospress.com
Recent years have seen tremendous progress towards therapy of many previously incurable
neuromuscular diseases. This new context has acted as a driving force for the development …

Rett syndrome: crossing the threshold to clinical translation

DM Katz, A Bird, M Coenraads, SJ Gray… - Trends in …, 2016 - cell.com
Lying at the intersection between neurobiology and epigenetics, Rett syndrome (RTT) has
garnered intense interest in recent years, not only from a broad range of academic scientists …

[HTML][HTML] Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases

MK Tsoumpra, S Fukumoto, T Matsumoto, S Takeda… - …, 2019 - thelancet.com
Duchenne muscular dystrophy (DMD) is an X-linked disorder characterized by progressive
muscle degeneration, caused by the absence of dystrophin. Exon skipping by antisense …

23Na MRI depicts early changes in ion homeostasis in skeletal muscle tissue of patients with duchenne muscular dystrophy

T Gerhalter, LV Gast, B Marty, J Martin… - Journal of Magnetic …, 2019 - Wiley Online Library
Background Duchenne muscular dystrophy (DMD) is a hereditary neuromuscular disease
leading to progressive muscle wasting. Since there is a need for MRI variables that serve as …

[HTML][HTML] Duchenne muscular dystrophy hiPSC–derived myoblast drug screen identifies compounds that ameliorate disease in mdx mice

C Sun, IY Choi, YIR Gonzalez, P Andersen… - JCI insight, 2020 - ncbi.nlm.nih.gov
Duchenne muscular dystrophy (DMD) is the most common muscular dystrophy. In the
present study, when human induced pluripotent stem cells (hiPSCs) were differentiated into …

Micropatterned substrates with physiological stiffness promote cell maturation and Pompe disease phenotype in human induced pluripotent stem cell‐derived skeletal …

N Jiwlawat, EM Lynch, BN Napiwocki… - Biotechnology and …, 2019 - Wiley Online Library
Recent advances in bioengineering have enabled cell culture systems that more closely
mimic the native cellular environment. Here, we demonstrated that human induced …

[HTML][HTML] CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review

H Babačić, A Mehta, O Merkel, B Schoser - PloS one, 2019 - journals.plos.org
Introduction The system of clustered regularly interspaced short palindromic repeats
(CRISPR) and CRISPR-associated proteins (cas) is a new technology that allows easier …

[HTML][HTML] Health-related quality of life and functional changes in DMD: a 12-month longitudinal cohort study

S Messina, GL Vita, M Sframeli, S Mondello… - Neuromuscular …, 2016 - Elsevier
In Duchenne muscular dystrophy (DMD) little has been reported on the association between
clinical outcome measures and patient health-related quality of life (HRQOL) tools. Our study …

Duchenne muscular dystrophy animal models for high-throughput drug discovery and precision medicine

NB Wasala, SJ Chen, D Duan - Expert opinion on drug discovery, 2020 - Taylor & Francis
Introduction: Duchenne muscular dystrophy (DMD) is an X-linked handicapping disease due
to the loss of an essential muscle protein dystrophin. Dystrophin-null animals have been …

Duchenne muscular dystrophy myogenic cells from urine-derived stem cells recapitulate the dystrophin genotype and phenotype

MS Falzarano, D D'Amario, A Siracusano… - Human gene …, 2016 - liebertpub.com
A ready source of autologous myogenic cells is of vital importance for drug screening and
functional genetic studies in Duchenne muscular dystrophy (DMD), a rare disease caused …